ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

11.37
BATS BZX Real-Time Price
As of 3:59pm ET
 +0.15 / +1.34%
Today’s Change
2.31
Today|||52-Week Range
14.40
+124.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.4B

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company currently in developmental stage that seeks to acquire, develop and commercialize, on its own or with commercial partners, a diverse portfolio of cancer therapies. The company also has a portfolio of small molecule drug candidates, which are no longer a strategic focus of its development activities for which the company is seeking partners to pursue further development and commercialization. It is currently focused on two clinical stage product candidates: Ad-RTS-IL-12 + veledimex and DC-RTS-IL-12 + veledimex. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Parris Building
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:

Employees

Shareholders

Individual stakeholders27.41%
Other institutional26.35%
Mutual fund holders12.26%

Top Executives

Laurence James Neil CooperChief Executive Officer & Managing Director
Caesar J. BelbelCOO, Secretary, Chief Legal Officer & Executive VP
Kevin G. LafondChief Financial Officer, Treasurer, CAO & VP
Francois LebelChief Medical Officer, EVP-Research & Development
Lynn M. FerrucciSVP-Human Resources, Facilities & Administration

To view my watchlist

Not a member yet?

Sign up now for a free account